@article{shah:hal-04069449,
TITLE = {Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study},
AUTHOR = {Shah, Bijal and Ghobadi, Armin and Oluwole, Olalekan and Logan, Aaron and Boissel, Nicolas and Cassaday, Ryan and Leguay, Thibaut and Bishop, Michael and Topp, Max and Tzachanis, Dimitrios and O'Dwyer, Kristen and Arellano, Martha and Lin, Yi and Baer, Maria and Schiller, Gary and Park, Jae and Subklewe, Marion and Abedi, Mehrdad and Minnema, Monique and Wierda, William and Deangelo, Daniel and Stiff, Patrick and Jeyakumar, Deepa and Dong, Jinghui and Adhikary, Sabina and Zhou, Lang and Schuberth, Petra and Faghmous, Imi and Masouleh, Behzad Kharabi and Houot, Roch},
URL = {https://univ-rennes.hal.science/hal-04069449},
JOURNAL = {Journal of Hematology and Oncology},
PUBLISHER = {BioMed Central},
VOLUME = {15},
NUMBER = {1},
PAGES = {170},
YEAR = {2022},
MONTH = Dec, DOI = {10.1186/s13045-022-01379-0},
KEYWORDS = {B-precursor acute lymphoblastic leukemia ; Brexucabtagene autoleucel ; CAR T-cell therapy ; KTE-X19 ; SCHOLAR-3 ; ZUMA-3},
PDF = {https://univ-rennes.hal.science/hal-04069449/file/s13045-022-01379-0},
HAL_ID = {hal-04069449},
HAL_VERSION = {v1},
}